Stock Day Media
Innovent Biologics, Inc. | Fifty 1 Labs, Inc.
Jun 20, 2024
· 0m
<div>Innovent Biologics, Inc. (HKEX: 01801), a world-class biopharmaceutical company announced that clinical data of IBI363 (first-in-class PD-1/IL-2 α-bias bispecific antibody fusion protein) in advanced solid tumors are presented at the 2024 ESMO Virtual Plenary.<br> <br> Fifty 1 Labs, Inc. (OTCPK: CAFI), a holding company that operates in the sports supplement, fitness equipment, and health and wellness industries is pleased to provide an update to its shareholders regarding recent strategic initiatives and significant developments within the company. Over the past several …
Este episodio no ha sido transcrito todavía.
Utilice STT.ai para transcribir este episodio con IA. Obtenga texto preciso con detección de altavoces, marcas de tiempo y exporte en varios formatos.
Detección de altavoces
Marcas temporales a nivel de palabra
Exportar como SRT, TXT, JSON